Evofem Biosciences Announced Strong Q3 2025 Financial Results and Updates on Strategies Evofem Biosciences reported a 10% increase in net sales and a substantial decrease in operating expenses for Q3 2025, signaling a strategic turnaround.

Evofem Biosciences Announced Strong Q3 2025 Financial Results and Updates on Strategies #USA #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI

Celebrating Contraceptive Choices for Women's Health on World Contraception Day Evofem Biosciences honors World Contraception Day, advocating for increased access to contraceptive options empowering women's health and freedom.

Celebrating Contraceptive Choices for Women's Health on World Contraception Day #United_States #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI

Evofem's 'Say Vagina' Campaign Achieves Over 2.5 Million Views in August Evofem Biosciences' innovative 'Say Vagina' campaign significantly raises awareness, generating over 2.5 million views and increasing engagement for its contraceptive brand PHEXXI.

Evofem's 'Say Vagina' Campaign Achieves Over 2.5 Million Views in August #PHEXXI #Evofem #Say_Vagina

Illinois Enacts New Law Allowing Pharmacists to Prescribe PHEXXI Contraceptive from 2026 Illinois has passed House Bill 3489 allowing pharmacists to prescribe PHEXXI, expanding contraceptive access for women by 2026.

Illinois Enacts New Law Allowing Pharmacists to Prescribe PHEXXI Contraceptive from 2026 #United_States #Illinois #Evofem_Biosciences #PHEXXI

Evofem Biosciences Shows Strong Q2 2025 Results and Future Plans Evofem Biosciences has reported promising financial outcomes for Q2 2025, highlighting significant growth and strategic initiatives aimed at enhancing women's health.

Evofem Biosciences Shows Strong Q2 2025 Results and Future Plans #USA #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI

Phexxi’s Viral TikTok Trend: Empowering Women Through Microfeminism Phexxi, a non-hormonal birth control brand, has captivated the internet with its TikTok campaign highlighting microfeminism, garnering attention from major media outlets.

Phexxi’s Viral TikTok Trend: Empowering Women Through Microfeminism #United_States #San_Diego #Evofem_Biosciences #PHEXXI #Microfeminism

Evofem's Hormone-Free Contraceptive PHEXXI Heads to UAE Market Approval Evofem Biosciences partners with Pharma 1 to seek UAE marketing approval for PHEXXI, a hormone-free contraceptive set to launch in 2026.

Evofem's Hormone-Free Contraceptive PHEXXI Heads to UAE Market Approval #United_Arab_Emirates #Dubai #Evofem_Biosciences #PHEXXI #Pharma_1

Evofem's First Quarter 2025 Financial Results: Growth Despite Challenges Ahead Evofem Biosciences reports Q1 2025 financial results highlighting both challenges and notable growth opportunities in women's health.

Evofem's First Quarter 2025 Financial Results: Growth Despite Challenges Ahead #USA #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI

Evofem Biosciences Announces Upcoming Participation in Emerging Growth Conference Evofem Biosciences is set to present at the Emerging Growth Conference on April 17, providing key insights into its innovative products in women's health.

Evofem Biosciences Announces Upcoming Participation in Emerging Growth Conference #United_States #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI

Watch for safety info. Jackie Giannelli discusses how #Phexxi can be a great option for women in perimenopause looking for non-hormonal birth control that fits their changing needs. #NonHormonal

See full prescribing information at www.phexxi.com.
Intended for US residents only.
EVFM-US-002209

Evofem and Windtree Therapeutics Join Forces for Cost-effective PHEXXI Manufacturing Evofem Biosciences has partnered with Windtree Therapeutics to significantly lower manufacturing costs of PHEXXI, aiming for broader global access.

Evofem and Windtree Therapeutics Join Forces for Cost-effective PHEXXI Manufacturing #USA #San_Diego #Evofem_Biosciences #PHEXXI #Windtree_Therapeutics

Evofem Biosciences Reports Fourth Year of Continuous Revenue Growth and Strategic Initiatives Evofem Biosciences, Inc. announces its fourth consecutive year of net sales growth with strategic plans for the future and improved operational costs.

Evofem Biosciences Reports Fourth Year of Continuous Revenue Growth and Strategic Initiatives #USA #San_Diego #Evofem_Biosciences #SOLOSEC #PHEXXI